Fosamprenavir calcium
Fosamprenavir Calcium is a prescription drug used to treat HIV infection by inhibiting the virus's protease enzyme. It comes as 700 mg oral tablets, manufactured by Sun Pharmaceutical Industries, Inc., and approved under ANDA204024. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Fosamprenavir Calcium is a prescription drug used to treat HIV infection by inhibiting the virus's protease enzyme. It comes as 700 mg oral tablets, manufactured by Sun Pharmaceutical Industries, Inc., and approved under ANDA204024. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Fosamprenavir calcium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Fosamprenavir calcium — ANDA 204024 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204024"
}
]
|
| identifier | ANDA204024 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"drug-safety",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Fosamprenavir calcium |
